NCT05690711View on ClinicalTrials.gov

A Trial of HRS8179 on Brain Swelling After Large Hemispheric Infarction

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 7, 2023

Primary Completion Date

December 5, 2023

Study Completion Date

February 27, 2024

Conditions
Brain Swelling, Large Hemispheric Infarction
Interventions
DRUG

HRS8179

HRS8179 injection

DRUG

Placebo

physiological saline

Trial Locations (1)

100050

Beijing Tiantan Hospital, Capital Medical University, Beijing

All Listed Sponsors
lead

Beijing Suncadia Pharmaceuticals Co., Ltd

INDUSTRY